- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
ComView upgrades cardiology Web site
After launching eTeleCardiology.com at last year's American College of Cardiology meeting (HNN 4/19/00) and gaining 3000 registered users in the first 30 days, ComView has refurbished the infrastructure of its cardiology Web site to add more
After launching eTeleCardiology.com at last year's American College of Cardiology meeting (HNN 4/19/00) and gaining 3000 registered users in the first 30 days, ComView has refurbished the infrastructure of its cardiology Web site to add more scalability features. The privately held firm has moved the eTeleCardiology image storage and transmission services onto a Linux platform, using Java Server Pages and Oracle's SQL database technology. ComView offers eTeleCardiology and the related ViewStar PC viewer free of charge, relying on sponsorships from companies such as Medtronic, Guidant, Eli Lilly, and Boston Scientific. The firm plans to expand its product offerings to include data storage and remote access.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
